Suscripción a Biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicado 6 números por año

ISSN Imprimir: 0743-4863

ISSN En Línea: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Lipid Nanocarriers: Influence of Lipids on Product Development and Pharmacokinetics

Volumen 28, Edición 4, 2011, pp. 357-393
DOI: 10.1615/CritRevTherDrugCarrierSyst.v28.i4.20
Get accessGet access

SINOPSIS

Lipid nanocarriers are on the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery. Owing to their size-dependent properties, lipid nanoparticles offer the possibility for development of new therapeutics and an alternative system to other colloidal counterparts for drug administration. An important point to be considered in the selection of a lipid for the carrier system is its effect on the properties of the nanocarrier and also its intended use, as different types of lipids differ in their nature. Researchers around the globe have tapped the potential of solid lipid nanoparticles (SLNs) in developing formulation(s) that can be administered by various routes such as oral, ocular, parenteral, topical, and pulmonary. Since the start of this millennium, a new generation of lipid nanoparticles, namely nanostructured lipid carriers (NLCs), lipid drug conjugates (LDCs), and pharmacosomes, has evolved that have the potential to overcome the limitations of SLNs. The current review article presents broad considerations on the influence of various types of lipids on the diverse characteristics of nanocarriers, encompassing their physicochemical, formulation, pharmacokinetic, and cytotoxic aspects.

CITADO POR
  1. Xu Wenting, Lim Soo-Jeong, Lee Mi-Kyung, Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer, Journal of Microencapsulation, 30, 8, 2013. Crossref

  2. Kiparissides Costas, Kammona Olga, Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules, The Canadian Journal of Chemical Engineering, 91, 4, 2013. Crossref

  3. Pathak Kamla, Raghuvanshi Smita, Oral Bioavailability: Issues and Solutions via Nanoformulations, Clinical Pharmacokinetics, 54, 4, 2015. Crossref

  4. Merhautova Jana, Demlova Regina, Slaby Ondrej, MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers, Frontiers in Pharmacology, 7, 2016. Crossref

  5. Deshpande Ameya, Mohamed Majrad, Daftardar Saloni B., Patel Meghavi, Boddu Sai H.S., Nesamony Jerry, Solid Lipid Nanoparticles in Drug Delivery, in Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices, 2017. Crossref

  6. Beloqui Ana, del Pozo-Rodríguez Ana, Isla Arantxazu, Rodríguez-Gascón Alicia, Solinís María Ángeles, Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs, Journal of Drug Delivery Science and Technology, 42, 2017. Crossref

  7. Silva Jessica, Mendes Maria, Cova Tânia, Sousa João, Pais Alberto, Vitorino Carla, Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles, AAPS PharmSciTech, 19, 5, 2018. Crossref

  8. Rouco Helena, Diaz-Rodriguez Patricia, Rama-Molinos Santiago, Remuñán-López Carmen, Landin Mariana, Delimiting the knowledge space and the design space of nanostructured lipid carriers through Artificial Intelligence tools, International Journal of Pharmaceutics, 553, 1-2, 2018. Crossref

  9. Kapoor Bhupinder, Gupta Reena, Singh Sachin Kumar, Gulati Monica, Singh Saranjit, Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes, Advances in Colloid and Interface Science, 253, 2018. Crossref

  10. Jin Shi-Jia, Jin Ming-Zhu, Xia Bai-Rong, Jin Wei-Lin, Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers, Frontiers in Oncology, 9, 2019. Crossref

  11. Beraldo-de-Araújo Viviane Lucia, Beraldo-de-Araújo Anderson, Costa Juliana Souza Ribeiro, Pelegrine Ana Carolina Martins, Ribeiro Lígia Nunes Moraes, Paula Eneida de, Oliveira-Nascimento Laura, Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions, Scientific Reports, 9, 1, 2019. Crossref

  12. Routray Sudhansu Bhusan, Patra Ch. Niranjan, Raju Rajarani, Panigrahi Kahnu Charan, Jena Goutam Kumar, Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study, Drug Development and Industrial Pharmacy, 46, 7, 2020. Crossref

  13. Al‐Husaini Khalsa, Elkamel Erij, Han Xiaoxia, Chen Pu, Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA delivery: Evidence in 3D spheroids of colon cancer cells, The Canadian Journal of Chemical Engineering, 98, 6, 2020. Crossref

  14. Harwansh Ranjit K., Bahadur Shiv, Deshmukh Rohitas, Rahman Md. A., Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective, Current Pharmaceutical Design, 26, 11, 2020. Crossref

  15. Rouco Helena, Diaz-Rodriguez Patricia, Remuñán-López Carmen, Landin Mariana, Recent advances in solid lipid nanoparticles formulation and clinical applications, in Nanomaterials for Clinical Applications, 2020. Crossref

  16. Wang Yi, Lai Wing-Fu, Systemic Delivery in Anti-aging Medicine: An Overview, in Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications, 13, 2020. Crossref

  17. Rouco Helena, Diaz-Rodriguez Patricia, Gaspar Diana P., Gonçalves Lídia M. D., Cuerva Miguel, Remuñán-López Carmen, Almeida António J., Landin Mariana, Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease, Nanomaterials, 10, 11, 2020. Crossref

  18. Xue Fangqin, Lin Xiao, Cai Zhixiong, Liu Xiaolong, Ma Yuan, Wu Ming, Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma, Colloids and Surfaces B: Biointerfaces, 197, 2021. Crossref

  19. Gandhi Gayatri, Abdullah Syahril, Foead Agus Iwan, Yeo Wendy Wai Yeng, The potential role of miRNA therapies in spinal muscle atrophy, Journal of the Neurological Sciences, 427, 2021. Crossref

  20. Slaby Ondrej, Laga Richard, Sedlacek Ondrej, Therapeutic targeting of non-coding RNAs in cancer, Biochemical Journal, 474, 24, 2017. Crossref

  21. Kyriakoudi Anastasia, Spanidi Eleni, Mourtzinos Ioannis, Gardikis Konstantinos, Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications, Plants, 10, 6, 2021. Crossref

  22. Limongi Tania, Susa Francesca, Marini Monica, Allione Marco, Torre Bruno, Pisano Roberto, di Fabrizio Enzo, Lipid-Based Nanovesicular Drug Delivery Systems, Nanomaterials, 11, 12, 2021. Crossref

  23. Kumbhar Popat, Shinde Tejaswini, Jadhav Tejaswini, Gavade Tejas, Sorate Rushikesh, Mali Uma, Disouza John, Manjappa Arehalli, Pharmacosomes: An approach to improve biopharmaceutical properties of drugs basic considerations in development, Research Journal of Pharmacy and Technology, 2021. Crossref

  24. PRIYANKA PALLERLA, SRI REKHA M., DEVI A. SEETHA, REVIEW ON FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES FOR VAGINAL APPLICATION, International Journal of Pharmacy and Pharmaceutical Sciences, 2022. Crossref

  25. Almeida Furquim de Camargo Bruna, Fonseca-Santos Bruno, Gonçalves Carvalho Suzana, Corrêa Carvalho Gabriela, Delello Di Filippo Leonardo, Sousa Araújo Victor Hugo, Lobato Duarte Jonatas, Polli Silvestre Amanda Letícia, Bauab Taís Maria, Chorilli Marlus, Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases, Critical Reviews in Microbiology, 2022. Crossref

  26. Sargazi Saman, Arshad Rabia, Ghamari Reza, Rahdar Abbas, Bakhshi Ali, Karkan Sonia Fathi, Ajalli Narges, Bilal Muhammad, Díez‐Pascual Ana M., siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review, Cell Biology International, 46, 9, 2022. Crossref

  27. Ehsan Sumia, Covarrubias-Zambrano Obdulia, Bossmann Stefan H., Mitochondrial Targeting Peptide-based Nanodelivery for Cancer Treatment, Current Protein & Peptide Science, 23, 10, 2022. Crossref

  28. Shinde R. R., Chaudhari B. P., Velhal A. B., Redasani V. K., Pharmacosome as a Vesicular Drug Delivery System, Asian Journal of Research in Pharmaceutical Sciences, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain